The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 958
ISSUE 958
September 29, 1995
Issue 958
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Intracavernous Injection of Alprostadil for Erectile Dysfunction
September 29, 1995 (Issue: 958)
An aqueous formulation of alprostadil (prostaglandin E 1 ; - Upjohn) has been approved by the US Food and Drug Administration (FDA) for injection into the corpus cavernosum to treat erectile dysfunction. The drug is also marketed as Prostin VR, an...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.